Pre-Hospital Intubation Factors and Pneumonia in Trauma Patients

Background: We reported similar rates of ventilator-associated pneumonia (VAP) previously in trauma patients intubated either in a pre-hospital (PH) venue or the emergency department. A subset of PH intubations with continuous quality assessment was re-examined to identify the intubation factors associated with VAP. Methods: The subgroup was derived from an existing data set of consecutive adult trauma patients intubated prior to Level I trauma center admission July 2007-July 2008. Intubation details recorded included bag-valve mask ventilation (BVM) and the presence of material in the airway. The diagnosis of VAP was made preferentially by quantitative bronchoalveolar lavage (BAL) cultures (10 4 colony-forming units indicating infection). Baseline data, injury characteristics, and circumstances of intubation of patients with and without VAP were compared by univariable analysis. Results: Detailed data were available for 197 patients; 32 (16.2%) developed VAP, on average 6.0 +/- 0.7 days after admission. Baseline characteristics were similar in the groups, but diabetes mellitus was more common in the VAP group (4 [12.5%] vs. 5 [3.0%]; p = 0.02). There was a higher rate of blunt injury in the VAP patients (28 [87.5%] vs. 106 [64.2%]; p = 0.01) and higher injury severity scores (33.1 +/- 2.8 vs. 23.0 +/- 1.0; p = 0.0002) and chest Abbreviated Injury Scores (2.6 +/- 0.3 vs. 1.5 +/- 0.1; p = 0.002). Lower Glasgow Coma Scale scores (7.9 +/- 0.9 vs. 9.9 +/- 0.4; p = 0.04) and greater use of BVM (18 [56.3%] vs. 56 [34.0%]; p = 0.02) were observed in patients who developed VAP. Among aspirations, 10 (31.3%) of patients with emesis developed VAP compared with only 4 (12.5%) with blood in the airway (p = 0.003). Conclusion: Aspiration, along with depressed consciousness and greater injury severity, may predispose trauma patients to VAP. Prospective studies should focus on the quality and timing of aspiration relative to intubation to determine if novel interventions can prevent aspiration or decrease the risk of VAP after aspiration.